Element Biosciences
Manufacturing · California, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
10055 Barnes Canyon Rd Ste 100, San Dieg...Phone Number
(619) 353-0300Website
www.elementbiosciences.comRevenue
$100.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
3
1
4
1
1
About Element Biosciences
Element Biosciences is a life sciences technology company that develops advanced genomic sequencing, multiomics, and biological analysis platforms for research and diagnostic applications. The company focuses on making high-quality biological data generation more accessible through innovative sequencing technologies, flexible workflows, and integrated analysis solutions that support scientific discovery across genomics, transcriptomics, proteomics, and spatial biology. By combining expertise in biology, engineering, software, and data science, Element Biosciences enables researchers, healthcare organizations, and biotechnology companies to accelerate breakthroughs in disease research, drug development, and precision medicine.Explore more
Element Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Element Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Element Biosciences launches new products
Earning: See what the market has to say on Element Biosciences recently announced quarterly report
Check if Element Biosciences has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Element Biosciences had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Element Biosciences
Element Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Element Biosciences has new funding data
Check out if Element Biosciences is spiking on competitors!
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Element Biosciences
Find more new buyers
Compare Similar Companies to Element Biosciences
Compare insights from companies similar to Element Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Element Biosciences
$100.3M
201-500
Private
$823M
2017
Michael PreviteChief Technology Officer & Senior VP, Research & Co-Founder, Development
$12.9M
201-500
Private
-
2000
Element Biosciences financials insights
Gather financial insights about Element Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Series A
$15M
2020
Series B
$80M
2021
Series C
$276M
2024
Series D
$277M
2026
Series E
$175M
Element Biosciences Tech Stack
A closer look at the technologies used by Element Biosciences
Most Recent Scoops
Project
Contracts
Hiring Plans
Element Biosciences has more open roles in Information Technology than it has had at any time in the past 12 months.
Hiring Plans
Open Position
Hiring Plans
Element Biosciences has more open roles in Sales than it has had at any time in the past 9 months. Technologies mentioned include: Salesforce.
Hiring Plans
Open Position
Element Biosciences News & Media
ABL Diagnostics Advances Platform-Agnostic NGS Strategy Through DeepChek® Verification on Element Biosciences’ AVITI™
Ongoing verification study supports compatibility of DeepChek® with the AVITI™ platform. Expands opportunities in infectious disease sequencing workflows. WOIPPY, FRANCE, June 9, 2026 /EINPresswire.com/ -- ABL Diagnostics (FR001400AHX6 – “ABLD”), a …SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine
BOSTON and SAN DIEGO, Nov. 11, 2025 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and Element Biosciences, Inc., a biology company transforming the pace and accessibility of scientific discovery, today announced at the Association for Molecular Pathology (AMP) Annual Meeting a partnership that unites sequencing and AI analytics to streamline genomic workflows and accelerate the research supporting precision medicine. This collaboration integrateTwist Bioscience and Element Biosciences Expand Collaboration to Transform Next Generation Sequencing Workflows with Co-Developed End-to-End Solutions
SOUTH SAN FRANCISCO, Calif. & SAN DIEGO--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, and Element Biosciences, Inc., a company democratizing access to advanced life science solutions, today announced an expanded collaboration to enable Element’s AVITI systems and Trinity flowcells with additional Twist library preparation and target enrichment workflows. “This collaboration bu
Read more news
Top Manufacturing Companies
Frequently Asked Questions Regarding Element Biosciences
Sign Up For FreeTo access detailed company insights
Element Biosciences is a life sciences technology company that develops advanced genomic sequencing, multiomics, and biological analysis platforms for research and diagnostic applications. The company focuses on making high-quality biological data generation more accessible through innovative sequencing technologies, flexible workflows, and integra... Read More
